NEW YORK CITY, NY / ACCESS Newswire / August 2, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ: RXST) between November 7, 2024 and July 8, 2025, both dates inclusive (the "Class Period", of the important September 22, 2025 lead plaintiff deadline. SO […]
NEW YORK, NY / ACCESS Newswire / August 2, 2025 / If you suffered a loss on your Replimune Group, Inc. (NASDAQ:REPL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/replimune-group-inc-lawsuit-submission-form?prid=159386&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK CITY, NY / ACCESS Newswire / August 2, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neogen Corporation (NASDAQ: NEOG) between January 5, 2023 and June 3, 2025, inclusive (the "Class Period"), of the important September 16, 2025 lead plaintiff deadline. SO WHAT:If
NEW YORK CITY, NY / ACCESS Newswire / August 2, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) between June 22, 2023 and June 24, 2025, both dates inclusive (the "Class Period"), of the important August 25, 2025 lead plaintiff deadline.
NEW YORK CITY, NY / ACCESS Newswire / August 2, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Sable Offshore Corp. (NYSE: SOC): (1) between May 19, 2025 and June 3, 2025, both dates inclusive (the
NEW YORK, NY / ACCESS Newswire / August 2, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form-3?prid=159355&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / August 2, 2025 / If you suffered a loss on your Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rocket-pharmaceuticals-inc-lawsuit-submission-form?prid=159354&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / August 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Exelixis, Inc. ("Exelixis, Inc.") (NASDAQ:EXEL) concerning possible violations of federal securities laws. Exelixis issued a press release on July 28, 2025, "report[ing] financial results for the second quarter of 2025" and "provid[ing]
NEW YORK, NY / ACCESS Newswire / August 2, 2025 / If you suffered a loss on your Centene Corporation (NYSE:CNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/centene-corporation-lawsuit-submission-form?prid=159358&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / August 2, 2025 / If you suffered a loss on your Neogen Corporation (NASDAQ:NEOG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neogen-corporation-lawsuit-submission-form?prid=159357&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call